Literature DB >> 33112803

Discovery of a possible role of asprosin in ovarian follicular function.

Excel Rio S Maylem1, Leon J Spicer1, Isadora Batalha2, Luis F Schutz2.   

Abstract

Asprosin is a novel fasting-induced protein encoded by fibrillin-1 (FBN1) gene, produced when FBN1 is cleaved by the enzyme furin, and is associated with insulin resistance and polycystic ovarian syndrome in humans. To characterize mRNA abundance of FBN1, FURIN, and the presumed asprosin receptor, olfactory receptor family 4 subfamily M member 1 (OR4M1) in granulosa (GC) and theca cells (TC), and identify hormones regulating FBN1 mRNA expression, GC and TC from small (1-5 mm; SM) and large (>8 mm; LG) follicles were collected from ovaries of heifers obtained at an abattoir and used for real-time PCR gene expression analysis or in vitro evaluation of hormone regulation and asprosin effects. SMTC had 151-fold greater (P < 0.05) FBN1 mRNA abundance than SMGC, and LGTC had 50-fold greater FBN1 mRNA than LGGC. In contrast, OR4M1 mRNA was 81-fold greater in SMGC than LGGC and did not differ from SMTC, but LGTC had 9-fold greater OR4M1 mRNA than LGGC. FURIN mRNA was 2.6-fold greater in SMTC than SMGC, but did not differ among follicular sizes. In cultured TC, leptin, insulin, LH, IGF1 and steroids did not affect FBN1 mRNA, but TGFB1 increased (P < 0.05) FBN1 mRNA by 2.2-fold; EGF and FGFs increased FBN1 mRNA by 1.3- to 1.5-fold. Asprosin enhanced LH-induced TC androstenedione production, reduced IGF1-induced TC proliferation, and had no effect on progesterone production. Developmental regulation of FBN1, FURIN and OR4M1 along with direct effects of asprosin on TC suggests that asprosin may be a novel regulator of ovarian follicular function.

Entities:  

Keywords:  asprosin; fibrillin-1; theca cells

Year:  2021        PMID: 33112803     DOI: 10.1530/JME-20-0218

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  5 in total

Review 1.  Caudamins, a new subclass of protein hormones.

Authors:  Bijoya Basu; Mahim Jain; Atul R Chopra
Journal:  Trends Endocrinol Metab       Date:  2021-10-16       Impact factor: 12.015

Review 2.  Asprosin, a C-Terminal Cleavage Product of Fibrillin 1 Encoded by the FBN1 Gene, in Health and Disease.

Authors:  Mehmet Akif Ovali; Ibrahim Bozgeyik
Journal:  Mol Syndromol       Date:  2022-02-08

3.  Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study.

Authors:  Nariman Moradi; Fatima Zahraa Fouani; Akram Vatannejad; Abbas Bakhti Arani; Soraya Shahrzad; Reza Fadaei
Journal:  Lipids Health Dis       Date:  2021-08-21       Impact factor: 3.876

4.  Asprosin-A Fasting-Induced, Glucogenic, and Orexigenic Adipokine as a New Promising Player. Will It Be a New Factor in the Treatment of Obesity, Diabetes, or Infertility? A Review of the Literature.

Authors:  Agnieszka Irena Mazur-Bialy
Journal:  Nutrients       Date:  2021-02-14       Impact factor: 5.717

5.  Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer.

Authors:  Rachel Kerslake; Cristina Sisu; Suzana Panfilov; Marcia Hall; Nabeel Khan; Jeyarooban Jeyaneethi; Harpal Randeva; Ioannis Kyrou; Emmanouil Karteris
Journal:  J Clin Med       Date:  2022-10-08       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.